Nov 3, 2026

The final 2027 outpatient / ASC payment rule is out (CMS-1850-F, November 4, 2026)

ASC rates rise 2.3% for ASCs meeting quality-reporting requirements (3.2% market basket minus 0.9 productivity adjustment); hospital outpatient rates also rise 2.3%. CMS finalizes paying 340B-acquired drugs at ASP minus 28%, removes 637 services from the inpatient-only list in year two of the three-year phase-out, and expands site-neutral payment to imaging without contrast at excepted off-campus provider-based departments. CMS adds 618 procedures to the ASC-covered procedures list in the final rule; none of the 618 are spine or orthopedic procedures.

The high-volume pain-procedure cuts are also confirmed in the final rule: transforaminal lumbar/sacral epidural injections (CPT 64483) fall 3%, tied with facet radiofrequency ablation, facet joint injections, and carpal tunnel release as the biggest losses among the highest-spending ASC procedures — the second year in a row CMS has lowered ASC rates for those procedures.

Sources: CMS fact sheet, November 4, 2026; Becker's Spine Review final-rule analysis, November 5, 2026. Note: the 618 count and the pain-procedure cuts rest on Becker's analysis of the final rule, not on the CMS fact sheet, which does not state either figure. Dollar rates for individual codes were not re-verified from the final rule text and are not quoted here.

Source not linkedIssue post

Jobs

All jobs

News

All news